Logo image of INL.DE

INTEL CORP (INL.DE) Stock Fundamental Analysis

FRA:INL - US4581401001 - Common Stock

20.785 EUR
-0.02 (-0.12%)
Last: 9/5/2025, 7:00:00 PM
Fundamental Rating

2

Overall INL gets a fundamental rating of 2 out of 10. We evaluated INL against 60 industry peers in the Semiconductors & Semiconductor Equipment industry. Both the profitability and financial health of INL have multiple concerns. INL does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

2

1. Profitability

1.1 Basic Checks

INL had positive earnings in the past year.
In the past year INL had a positive cash flow from operations.
Of the past 5 years INL 4 years were profitable.
INL had a positive operating cash flow in each of the past 5 years.
INL.DE Yearly Net Income VS EBIT VS OCF VS FCFINL.DE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10B -10B 20B 30B

1.2 Ratios

With a Return On Assets value of -10.65%, INL is not doing good in the industry: 86.67% of the companies in the same industry are doing better.
Looking at the Return On Equity, with a value of -20.95%, INL is doing worse than 86.67% of the companies in the same industry.
Industry RankSector Rank
ROA -10.65%
ROE -20.95%
ROIC N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
INL.DE Yearly ROA, ROE, ROICINL.DE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 -10 20

1.3 Margins

The Gross Margin of INL (29.76%) is worse than 88.33% of its industry peers.
INL's Gross Margin has declined in the last couple of years.
INL does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 29.76%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
INL.DE Yearly Profit, Operating, Gross MarginsINL.DE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 60

1

2. Health

2.1 Basic Checks

INL does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, INL has more shares outstanding
Compared to 5 years ago, INL has more shares outstanding
INL has a better debt/assets ratio than last year.
INL.DE Yearly Shares OutstandingINL.DE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B 4B
INL.DE Yearly Total Debt VS Total AssetsINL.DE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50B 100B 150B

2.2 Solvency

INL has an Altman-Z score of 1.26. This is a bad value and indicates that INL is not financially healthy and even has some risk of bankruptcy.
INL has a worse Altman-Z score (1.26) than 83.33% of its industry peers.
INL has a Debt/Equity ratio of 0.47. This is a healthy value indicating a solid balance between debt and equity.
INL's Debt to Equity ratio of 0.47 is on the low side compared to the rest of the industry. INL is outperformed by 70.00% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Altman-Z 1.26
ROIC/WACCN/A
WACC9.59%
INL.DE Yearly LT Debt VS Equity VS FCFINL.DE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20B 40B 60B 80B 100B

2.3 Liquidity

A Current Ratio of 1.24 indicates that INL should not have too much problems paying its short term obligations.
Looking at the Current ratio, with a value of 1.24, INL is doing worse than 85.00% of the companies in the same industry.
INL has a Quick Ratio of 1.24. This is a bad value and indicates that INL is not financially healthy enough and could expect problems in meeting its short term obligations.
INL's Quick ratio of 0.92 is on the low side compared to the rest of the industry. INL is outperformed by 78.33% of its industry peers.
Industry RankSector Rank
Current Ratio 1.24
Quick Ratio 0.92
INL.DE Yearly Current Assets VS Current LiabilitesINL.DE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B 40B 50B

3

3. Growth

3.1 Past

INL shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -53.91%.
The earnings per share for INL have been decreasing by -36.62% on average. This is quite bad
The Revenue has decreased by -3.72% in the past year.
INL shows a decrease in Revenue. Measured over the last years, the Revenue has been decreasing by -5.90% yearly.
EPS 1Y (TTM)-53.91%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%400%
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%0.2%

3.2 Future

INL is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 41.29% yearly.
Based on estimates for the next years, INL will show a small growth in Revenue. The Revenue will grow by 4.51% on average per year.
EPS Next Y-73.98%
EPS Next 2Y15.21%
EPS Next 3Y36.39%
EPS Next 5Y41.29%
Revenue Next Year-1.09%
Revenue Next 2Y1.04%
Revenue Next 3Y2.19%
Revenue Next 5Y4.51%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is accelerating: in the next years the growth will be better than in the last years.
INL.DE Yearly Revenue VS EstimatesINL.DE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 20B 40B 60B
INL.DE Yearly EPS VS EstimatesINL.DE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 0 1 2 3 4 5

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 45.18, which means the current valuation is very expensive for INL.
Compared to the rest of the industry, the Price/Earnings ratio of INL indicates a slightly more expensive valuation: INL is more expensive than 70.00% of the companies listed in the same industry.
When comparing the Price/Earnings ratio of INL to the average of the S&P500 Index (27.06), we can say INL is valued expensively.
Based on the Price/Forward Earnings ratio of 36.48, the valuation of INL can be described as expensive.
Based on the Price/Forward Earnings ratio, INL is valued a bit more expensive than the industry average as 76.67% of the companies are valued more cheaply.
The average S&P500 Price/Forward Earnings ratio is at 22.69. INL is valued rather expensively when compared to this.
Industry RankSector Rank
PE 45.18
Fwd PE 36.48
INL.DE Price Earnings VS Forward Price EarningsINL.DE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30 40

4.2 Price Multiples

INL's Enterprise Value to EBITDA ratio is in line with the industry average.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 16.17
INL.DE Per share dataINL.DE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 5 10 15

4.3 Compensation for Growth

A more expensive valuation may be justified as INL's earnings are expected to grow with 36.39% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y15.21%
EPS Next 3Y36.39%

0

5. Dividend

5.1 Amount

No dividends for INL!.
Industry RankSector Rank
Dividend Yield N/A

INTEL CORP

FRA:INL (9/5/2025, 7:00:00 PM)

20.785

-0.02 (-0.12%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSemiconductors & Semiconductor Equipment
GICS IndustrySemiconductors & Semiconductor Equipment
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-29 2025-10-29/amc
Inst Owners67.73%
Inst Owner ChangeN/A
Ins Owners0.03%
Ins Owner ChangeN/A
Market Cap90.98B
Analysts57.25
Price Target19.33 (-7%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.32
Dividend Growth(5Y)-21.66%
DP-2.61%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)1282.57%
Min EPS beat(2)725.25%
Max EPS beat(2)1839.89%
EPS beat(4)4
Avg EPS beat(4)869.45%
Min EPS beat(4)2.81%
Max EPS beat(4)1839.89%
EPS beat(8)7
Avg EPS beat(8)441.11%
EPS beat(12)10
Avg EPS beat(12)342.03%
EPS beat(16)13
Avg EPS beat(16)257.53%
Revenue beat(2)2
Avg Revenue beat(2)3.37%
Min Revenue beat(2)0.96%
Max Revenue beat(2)5.79%
Revenue beat(4)4
Avg Revenue beat(4)2%
Min Revenue beat(4)0.02%
Max Revenue beat(4)5.79%
Revenue beat(8)5
Avg Revenue beat(8)0.62%
Revenue beat(12)7
Avg Revenue beat(12)0.62%
Revenue beat(16)9
Avg Revenue beat(16)0.16%
PT rev (1m)0.5%
PT rev (3m)-0.86%
EPS NQ rev (1m)8.04%
EPS NQ rev (3m)-95.3%
EPS NY rev (1m)-57.16%
EPS NY rev (3m)-58.44%
Revenue NQ rev (1m)0.01%
Revenue NQ rev (3m)-5.06%
Revenue NY rev (1m)0.34%
Revenue NY rev (3m)3.08%
Valuation
Industry RankSector Rank
PE 45.18
Fwd PE 36.48
P/S 2
P/FCF N/A
P/OCF 10.51
P/B 1.08
P/tB 1.49
EV/EBITDA 16.17
EPS(TTM)0.46
EY2.21%
EPS(NY)0.57
Fwd EY2.74%
FCF(TTM)-2.15
FCFYN/A
OCF(TTM)1.98
OCFY9.51%
SpS10.41
BVpS19.2
TBVpS13.91
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -10.65%
ROE -20.95%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 29.76%
FCFM N/A
ROA(3y)-1.42%
ROA(5y)4.24%
ROE(3y)-3.13%
ROE(5y)7.44%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.17%
GM growth 5Y-11.02%
F-Score4
Asset Turnover0.28
Health
Industry RankSector Rank
Debt/Equity 0.47
Debt/FCF N/A
Debt/EBITDA 6.1
Cap/Depr 176%
Cap/Sales 39.62%
Interest Coverage N/A
Cash Conversion 133.55%
Profit Quality N/A
Current Ratio 1.24
Quick Ratio 0.92
Altman-Z 1.26
F-Score4
WACC9.59%
ROIC/WACCN/A
Cap/Depr(3y)223.59%
Cap/Depr(5y)192.25%
Cap/Sales(3y)44.1%
Cap/Sales(5y)35.32%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-53.91%
EPS 3Y-54.95%
EPS 5Y-36.62%
EPS Q2Q%400%
EPS Next Y-73.98%
EPS Next 2Y15.21%
EPS Next 3Y36.39%
EPS Next 5Y41.29%
Revenue 1Y (TTM)-3.72%
Revenue growth 3Y-12.41%
Revenue growth 5Y-5.9%
Sales Q2Q%0.2%
Revenue Next Year-1.09%
Revenue Next 2Y1.04%
Revenue Next 3Y2.19%
Revenue Next 5Y4.51%
EBIT growth 1Y-963.85%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year1300.23%
EBIT Next 3Y182.59%
EBIT Next 5Y96.64%
FCF growth 1Y34.66%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y3.34%
OCF growth 3Y-34.47%
OCF growth 5Y-24.21%